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Abstract Objective: To determine
to what extent patients who have
survived abdominal sepsis suffer from
symptoms of posttraumatic stress
disorder (PTSD) and depression,
and to identify potential risk factors
for PTSD symptoms. Design and
setting: PTSD and depression symp-
toms were measured using the Impact
of Events Scale–Revised (IES-R), the
Post-Traumatic Symptom Scale 10
(PTSS-10) and the Beck Depression
Inventory II (BDI-II). Patients and
participants: A total of 135 peri-
tonitis patients were eligible for this
study, of whom 107 (80%) patients
completed the questionnaire. The me-
dian APACHE-II score was 14 (range
12–16), and 89% were admitted to the
ICU. Measurementsand results: The
proportion of patients with “moder-
ate” PTSD symptom scores was 28%
(95% CI 20–37), whilst 10% (95%
CI 6–17) of patients had “high” PTSD
symptom scores. Only 5% (95%
CI 2–12) of the patients expressed
severe depression symptoms. Factors665
associated with increased PTSD
symptoms in a multivariate ordinal
regression model were younger age
(0.74 per 10 years older, p=0.082),
length of ICU stay (OR= 1.4 per
doubling of duration, p= 0.003) and
having some (OR =4.9, p=0.06)
or many (OR =55.5, p<0.001)
traumatic memories of the ICU or
hospital stay. Conclusion: As many
as 38% of patients after abdominal
sepsis report elevated levels of PTSD
symptoms on at least one of the ques-
tionnaires. Our nomogram may assist
in identifying patients at increased
risk for developing symptoms of
PTSD.
Keywords Peritonitis · Sepsis ·
Posttraumatic stress disorder · PTSD ·
Depression · Intensive care · IES-R ·
PTSS-10 · BDI-II
Abbreviations APACHE-II: Acute
Physiology and Chronic Health
Evaluation II · ARDS: Acute
respiratory distress syndrome ·
APS: Acute Physiology Score ·
DSM-IV: Diagnostic and Statistical
Manual of Mental Disorders–Fourth
Edition · ICU: Intensive care unit ·
IQR: Interquartile range ·
IES-R: Impact of Events–Revised
Questionnaire · N: Number of
patients · n.a.: Not applicable ·
OR: Odds ratio · PTSD: Post-
traumatic stress disorder ·
PTSS-10: Post-Traumatic Stress
Syndrome 10-Questions Inventory ·
SCID: Standardized Clinical
Interview Diagnosis · SD: Standard
deviation · 95% CI: 95% Conﬁdence
intervals
Introduction
Posttraumatic stress disorder (PTSD) is the development
of psychological and physical symptoms following expo-
sure to one or more traumatic events [1, 2]. PTSD symp-
toms include intrusive recollections (re-experiencing the
trauma in ﬂashbacks, memories or nightmares); avoidant
and numbing symptoms (including diminished emotions
and avoidance of situations that are reminders of the trau-
matic event); and hyperarousal (including increased irri-
tability, exaggerated startle reactions or difﬁculty sleeping
or concentrating) [3]. PTSD symptoms have a major im-
pact on life, illustrated by the fact that the patients have
a reduced quality of life [4] and frequently suffer from de-
pression [5].
Events that typically trigger the development of PTSD
include exposure to violent events such as rape, domestic
violence, child abuse, war, accidents, natural disasters and
political torture, all of which include a threat to life [6–8].
Increasingly PTSD has also been found in patients who
havesurviveda major,life-threateningdiseaseandpatients
who have spent a signiﬁcant amount of time in an inten-
sive care unit (ICU) [9–13]. Severe peritonitis (or abdomi-
nal sepsis) is such a disease where typically an episode of
acute and severe illness [14, 15] is followed by a lengthy
ICU stay and a long recovery period that often includes
multiple surgical and non-surgical interventions [16–22].
This combination of factors could make this patient group
particularly vulnerable for developing PTSD symptoms.
To date, little is known about the presence and severity of
PTSD and possible risk factors in patients recoveringfrom
severe peritonitis [15].
Therefore, our aims were to determine the presence
and level of symptoms of PTSD in patients surviving ab-
dominal sepsis. In addition, we searched for demographic
and disease-related factors associated with higher levels
of PTSD symptoms. Identiﬁcation of such factors may
be important to determine possible targets of intervention
and to select patients for psychological assessment inter-
views.
Methods
Study design
Our study was embedded in an ongoing randomized clin-
ical trial (the RELAP Trial) evaluating two surgical treat-
ment strategies for patients with secondaryperitonitis after
the initial emergency laparotomy. Patients were enrolled
between December 2001 and February 2005 in two aca-
demic medical centers and seven regional teaching hospi-
tals in The Netherlands. All patients were followed up for
12 months after initial (index) laparotomy.
The study was approved by the medical ethics com-
mittee of the Academic Medical Center, Amsterdam. All
patients gave informed consent to participate in this study.
Study population
Patients were eligible for the RELAP trial if they had
a clinical diagnosis of secondary peritonitis requiring
emergency laparotomy and an Acute Physiology and
Chronic Health Evaluation II (APACHE-II) score above
10. Further details of the study population can be found
elsewhere [23].
Data collection
All self-administered PTSD questionnaires were distrib-
uted by mail to patients who survived at least 12 months
following initial emergency laparotomy, with a reminder
by phone within 2 weeks in the case of no response. After666
1 month without response a new questionnaire including
a reminder letter was sent.
Instruments assessing the level of PTSD symptoms
We used two instruments with good psychometric char-
acteristics [24, 25] for measuring PTSD symptoms in re-
search settings: the Post-Traumatic Stress Scale 10 [26]
and the Impact of Event Scale–Revised [27, 28].
The Post-Traumatic Stress Syndrome Scale 10 (PTSS-
10) was originally designed to diagnose PTSD according
to the Diagnostic and Statistical Manual of Mental Dis-
orders III (DSM-III) criteria in victims of natural disas-
ters [14]. The PTSS-10 is now a widely used self-report
questionnaire assessing symptoms related to PTSD, par-
ticularly in critically ill and ICU patients [4, 11, 12]. The
PTSS-10 consists of 10 items, each of which ranges from
1 point (none) to 7 points (always). The total score ranges
from 10 to 70, with higher scores indicating more symp-
toms; scores of 35 or above are considered indicative of
PTSD [11, 29].
The Impact of Events Scale–Revised (IES-R) is one of
the most commonly used self-report questionnaires for de-
terminingPTSD symptomatologyfollowinga trauma[27].
The IES-R consists of 22 items, each ranging from 0 (no
problems) to 4 (frequent problems), with the total score
ranging from 0 to 66. Scores above 24 points are generally
considered indicative of PTSD, with higher scores indicat-
ing more symptoms [28]. The IES-R has been developed
based on DSM-IV criteria and therefore has three distinct
subscales, the avoidance subscale (eight questions), the
intrusion subscale (eight questions) and the hyperarousal
subscale (six questions) [28, 30], and is one of the most
frequently used self-report questionnaires in both the
clinic and in PTSD research [27].
Potential risk factors
Potential risk factors were selected from previous stud-
ies [31] examining factors for increased mortality and
morbidity [17–22, 32, 33] in secondary peritonitis sup-
plemented with speciﬁc factors mentioned in the PTSD
literature [6, 9–11, 14, 34, 35]. We divided these factors
into three distinct categories.
General patient characteristics included age, gender
andthe presenceof major comorbidity(cardiovasculardis-
ease; COPD; renal failure; diabetes; malignancy).
Disease characteristics and postoperative course
included severity of disease measured at the time of initial
laparotomy using the APACHE-II score. As several com-
ponents of the APACHE-II score are already considered
in a univariate analysis (namely age and comorbidity); we
chose to replace the APACHE-II score with the APS score
as a potential predictor of PTSD [36]. The APS comprises
only the acute components of the APACHE-II score,
without age and comorbidity. Postoperative characteristics
included administration of hydrocortisone during ICU
stay [13, 37], development of acute respiratory distress
syndrome (ARDS), [4, 12, 20], number of relaparotomies,
duration of ICU and hospital stay, the development of
a disease-related major morbidity during 6 months’
follow-up [23] and an enterostomy present after 6 months’
follow-up.
Traumatic memories of ICU/hospital stay were
assessed using the four-item adverse experiences ques-
tionnaire,whichcapturesfourtypesoftraumaticmemories
of the stay in the ICU or hospital ward: nightmares, fear
and panic, pain, and difﬁculty in breathing [13]. Patients
scored the frequency of traumatic memories of their stay
in the ICU or hospital ward using a four-point scale
of 0 (never), 1 (sometimes), 2 (regularly) or 3 (often),
administered concurrently with the PTSS-10 and IES-R
questionnaires after at least 12 months’ follow-up. These
were subsequently summed and classiﬁed into three
graded categories of traumatic memories: 0 (no traumatic
memories), 1–4 (some traumatic memories), more than 4
(many traumatic memories).
We also collected data on whether patients had expe-
rienced other traumas or whether a close family member
or friend had experienced a trauma within the previous
3 years. We used questions 29 and 30 from the Life
Stressor Checklist–Revised [38], administered at the
same time as the PTSS-10, IES-R and Beck Depression
Inventory II (BDI-II) questionnaires. Responses were
given dichotomously as yes or no, and patients were
subsequently asked to specify the event type [38]. These
questions were asked to determine to what extent the
PTSD symptomatology found in this patient group was
due to their peritonitis or to other traumatic events.
Data analysis
We used two instruments aimed at measuring the presence
and severity of PTSD symptoms in our population, each
with their own cut-off value. Combining data from two
instruments measuring the same construct (PTSD symp-
toms) may lead to a more robust classiﬁcation of patients.
To preservethe natural orderingof patients who scored be-
low the cut-off value on both questionnaires (‘low-scoring
patients’), patients scoring above the cut-off on only one
of these questionnaires (‘moderate scoring patients’) and
patients scoring above the cut-off on both questionnaires
(‘high-scoring patients’), we applied ordinal regression
modeling. The proportion of patients in each of these three
categories is presented with 95% conﬁdence intervals
(95% CI) using the method of Wilson [39].
Potential predictors for PTSD symptoms were ana-
lyzed using an ordinal logistic regression model. This
ordinal regression model is an extension of the binary667
logistic model and is appropriate when a continuous trait
is grouped into several categories by using cut-offs [40].
All potential predictors for PTSD symptoms were ﬁrst
examined in univariate ordinal regression models. Factors
with a p-value of less than 0.1 were entered in a multivari-
ate ordinal logistic regression model. If variables within
a group of predictors were strongly correlated, only the
factor with the strongest univariate relationship and/or
most relevant clinical interpretation was added to the
model. Because the literature on PTSD and ICU studies
shows them to be clinically relevant, age and gender were
always included in the multivariate model regardless of
the strength of their associations [34].
In addition, a factor comprised of other non-related
traumas that the patient had experienced within the
previous 3 years was included in the ﬁnal model to assess
its potential confounding role.
The ﬁt and validity of the model was evaluated
by checking the discriminatory properties (overlap in
risk scores of patients with different outcomes), the
proportional odds assumption (test for parallel lines)
and calibration (closeness in expected and observed
numbers of patients evaluated by an extension of the
Hosmer–Lemeshow goodness-of-ﬁt statistic).
Calibration was checked by comparing expected and
observed number of patients in each of the three outcome
categories across deciles of expected risk and tested
Fig.1 Flowchart summarizing
inclusion and response
for signiﬁcance by using an extension of the Hosmer–
Lemeshow goodness-of-ﬁt statistic [41].
Nomogram: A nomogram was developed to visualize
the prognostic strength of the different factors from the
multivariate model in a single diagram. A nomogram al-
lows readers to calculate an expected distribution of PTSD
symptomatology (‘low-scoring’, ‘moderate-scoring’ and
‘high-scoring’ patients) based on a speciﬁc proﬁle of
a patient. The number of points for each predictor was
based on the original coefﬁcient from the multivariate
ordinal model. The total number of points derived by
specifying values for all predictors was used to calcu-
late the expected probabilities that a patient would be
a ‘low-scoring patient’, a ‘moderate-scoring patient’ or
a ‘high-scoring patient’.
Analyses were performed using SAS software version
9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Of the total of 132 patients eligible for this study, 108
(80%) patients responded to the questionnaire (Fig. 1).
On average the responses were provided approximately
12.5 months following initial emergency laparotomy.
There were no signiﬁcant differences in any of the668
patient or disease characteristics between respondents and
non-respondents.
The median age of patients was 66.8 years and 54%
were male. Patients were severely ill, with a median
APACHE-II score of 14 and a median APS score of 6,
and 5% had a major comorbidity (Table1). Ninety-six
patients (89%) were admitted to ICU: their median
ICU-stay was 7 days, and these patients were me-
chanically ventilated for a median of 5 days. Patients
were hospitalized for a median period of 28 days (IQR
19–55 days). Fifty-one percent of patients also underwent
Table 1 Association between severityof PTSDsymptoms (three categories) and patient, disease operative and postoperative characteristics:
results from univariate ordinal regression models
Overall PTSD symptoms a (n=107) Univariate
ordinal
regression b
None to mild Moderate High p-value
(n=66) (n=30) (n=11)
General patient characteristics
Median age (IQR) 66.8 (57–73) 70.2 (60–74) 58.7 (47–72) 57.8 (49–65) 0.004
Male gender (%) 54% 53% 53% 64% 0.847
Major comorbidity present (%) c 53% 55% 50% 55% 0.670
Peritonitis and postoperative characteristics
Initial
Median APS score (IQR) 6 (4–8) 6 (4–8) 7 (5–9) 8 (3–8.5) 0.271
Hydrocortisone in ﬁrst 14 days in ICU 2 (0–7) 1.5 (0–8) 1 (0–8) 5 (1–7) 0.749
(median days)
ARDS 6% 3% 10% 9% 0.192
One or more relaparotomies 67% 70% 63% 64% 0.515
Admitted to ICU 89% 85% 93% 100% 0.110
Median length of ICU stay (IQR) 7 (4–15) 7 (4–12) 7 (4–19) 9 (6–16) 0.042
Median ventilation time (IQR) 5 (1–8) 4 (1–7) 5 (1–10) 7 (4–13) 0.073
Median length of hospital stay (IQR) 28 (19–55) 26 (18–47) 31 (23–60) 56 (19–72) 0.102
Follow-up
Disease-related major morbidity 15% 9% 27% 18% 0.068
at 6-month follow-up
Enterostomy at 6-month follow-up 51% 47% 55% 70% 0.183
IQR, Interquartile range; a Three graded outcomes: none to mild, moderate and high; two patients’ data are based on only one completed
questionnaire; b All models were checked for parallel lines to see if an ordinal test for signiﬁcance was appropriate; c Major comorbidity
included cardiovascular disease, COPD, renal failure, diabetes and malignancy
PTSD symptoms (n=105) Univariate
ordinal
regression
None to mild Moderate High p-value
(n=64) a (n=30) a (n=11)
Traumatic memories of ICU or hospital stay
Nightmares 39% 61% 82% 0.002
Fear and panic 24% 61% 100% <0.001
Pain 67% 70% 82% 0.002
Difﬁculty breathing 33% 76% 100% <0.001
Traumatic memories
None (0) 41% 50% 9% <0.001
Moderate (1–4) 7% 47% 47%
Severe (>4) 0% 18% 82%
a Two patients not included in ﬁnal analysis due to missing data on traumatic memories during ICU or
hospital stay
Table 2 Association between
severity of PTSD symptoms
(three categories) and other
traumatic experiences following
peritonitis
another trauma in the 3 years prior to ﬁlling in the PTSD
questionnaires.
Prevalence of PTSD symptoms
The proportion of ‘moderate-scoring’ PTSD patients was
28% (95% CI 20–37%), whilst 10% (95% CI 6–17%)
of patients were ‘high-scoring’ patients (Table1). De-
tailed information on depression and PTSD symptoms is
presented in the electronic supplementarymaterial (ESM).669
Fig.2 Nomogram for prediction
of severity of PTSD symptoms
in patients with secondary
peritonitis. Graded outcome
categories are: none to mild
(negative on both instruments),
moderate (positive on one
instrument), and severe (positive
on both instruments)
Predictive factors
Results from the univariate analysis are presented in
Table1 and Table2, and descriptive details can be found
in the ESM.
The ﬁnal multivariate model included age, gender,
length of ICU stay, disease-related morbidity during
the 6-month follow-up, traumatic memories of the ICU
or hospital stay and other traumatic factors within the
previous 3 years (Table3).670
Final model (n=105) a
OR 95% CI p-value
Lower Upper
Ten years increase in age 0.74 0.53 1.04 0.084
Female 0.9 0.94 2.3 0.822
Length of ICU stay (log2 transformed) 1.4 1.1 1.7 <0.003
Major disease-related morbidity during 6-month 2.1 0.61 7.11 0.238
follow-up (including index hospital admittance)
Traumatic memories of ICU or hospital stay
Moderate (1–4) 4.9 0.95 24.9 0.058
Severe (>4) 55.5 9.4 328.0 <0.001
Other trauma within previous 3 years 2.4 0.94 6.3 0.085
a This multivariate ordinal analysis included a test for parallel lines (p=0.694)
Table 3 Association between
severity of PTSD symptoms and
patient, disease operative and
postoperative characteristics and
other traumatic experiences
following peritonitis in
a multivariate analysis
Fig.3 Distribution of total
points from nomogram (risk
score) for the prediction of the
severity of PTSD symptoms
with use of the risk factors taken
from the multivariate ordinal
model. PTSD categories are
graded according to severity:
none to mild (negative on both
instruments), moderate (positive
on one instrument), severe
(positive on both instruments)
In our ﬁnal model, increasing age was associated with
a lower likelihood of PTSD symptomatology (OR =0.74
per 10 years increase in age, p= 0.084). Gender was
not predictive of PTSD symptoms (OR = 0.90, p=0.82).
Disease-related morbidity at the 6-month follow-up
(OR =2.1, p= 0.24) was no longer independently predic-
tive of PTSD symptoms. Memories of the ICU/hospital
stay (patients that reported some memories: OR= 4.9,
p< 0.057; patients that reported many memories:
OR= 55.5, p<0.001) were the most prominent inde-
pendent risk factor for increased PTSD symptomatology.
Length of ICU stay was also signiﬁcantly predictive in
the development of PTSD symptomatology in the multi-
variate model (OR =1.4, p= 0.004). The relative strengths
of these relationships are visualized in the nomogram
(Fig.2). In this nomogram, one can calculate for the
individual patient given his/her risk proﬁle the probability
that he/she will score either no to mild, moderate or671
high PTSD symptoms according to the PTSS-10 and
IES-R.
The proportional odds assumption was not violated as
indicated by a p-valueof 0.694 for the test of parallel lines.
Calibration of the model (closeness between predicted and
observed probabilities) was good, with a p-value of 0.987
for the goodness-of-ﬁt test for ordinal models. A graphical
impression of the model’s discriminative ability is shown
in Fig. 3. This ﬁgure shows that the mean risk score is
signiﬁcantly different between all three PTSD symptom
severity categories (p< 0.001), although there is some
substantial overlap in the risk scores between patients
from different categories of PTSD symptom severity.
Discussion
The proportion of patients with ‘high-scoring’ PTSD
symptomatology 12 months after peritonitis was 10%,
and the number of ‘medium-scoring’ patients (28%) was
in line with earlier studies measuring PTSD symptoms in
critically ill patients who had been admitted to ICU [9–13,
15, 42]. The prevalence of PTSD recorded in the general
population varies between 0.9% and 2.9% (the ESEMeD
study) [7, 43, 44].
From our study, the following observations can be
made. Firstly, the development of PTSD symptoms is not
directly related to the severity of the disease at presen-
tation. The APS score at baseline was not predictive for
the development of PTSD symptoms. The APS measures
the severity of disease score solely on the weight of the
acute clinical features and does not incorporate age and
comorbidity [36].
The development of PTSD symptoms was, however,
predominantly related to a more complicated course of
secondary peritonitis. Longer ICU and hospital stays and
major disease-related morbidity during the 12-month
follow-up were associated with more PTSD symptoms.
In concordance with earlier studies [15, 34], the strongest
predictor of having PTSD symptoms following abdominal
sepsis was having traumatic memories and experiences
during their initial hospital or ICU stay. These results
suggest that the presence of traumatic memories is one
of the most relevant aspects for the development of
PTSD-related symptoms. Earlier studies also found that
subjective interpretation of the intensive care experience
emerged as a consistent predictor of adverse emotional
outcome in both the short and the long term [13, 34].
Age plays a critical role in the development of PTSD
symptoms. Younger patients are much more likely to de-
velop and report such symptoms. This ﬁnding conﬁrms
the results of an earlier, retrospective study of a different
cohort of patients 4–10 years after hospital admission for
severe peritonitis [15]. These ﬁndings suggest that older
patients are more able to adapt to the limitations that are
associated with experiencing such a major disease, most
likely because they have already experienced a co-morbid
illness and health-related problems. In contrast to some
otherstudies,genderdid notplay a role in thedevelopment
of PTSD symptoms [34].
Patients with abdominal sepsis suffering from ARDS
did not report more PTSD symptomatology than those
without ARDS. In earlier ICU studies, ARDS patients
reported considerable PTSD symptoms [12, 45]. In our
cohort of abdominal sepsis patients we found different
predictive factors for PTSD than those found in the
ARDS patients [10, 12, 15]. Secondary peritonitis in itself
may have been severe enough, with ICU admission and
extended mechanical ventilation days, to cause PTSD
symptoms; therefore, the added risk by ARDS may be
moot. Lack of power may also be a factor, because the
proportion of patients developing ARDS in this study was
modest.
We did not ﬁnd an association between hydrocortisone
administration during ICU stay and PTSD symptoms
within this peritonitis cohort, as has been demonstrated
for other critically ill patient groups [13, 37, 46, 47].
Hydrocortisone did not protect against developing PTSD
symptoms, whereas other studies have found that ad-
ministration of hydrocortisone during ICU can lead to
a reduction in PTSD symptoms after discharge. In this
study corticosteroid use during only the ﬁrst 14 days of
ICU was included in our analyses. The effect of prolonged
use of hydrocortisone or late-stage use during conditional
adrenal insufﬁciency cannot be excluded.
Unfortunately, due to the acute and life-threatening na-
ture of secondary peritonitis, it was not possible to col-
lect baseline information on PTSD or data on earlier psy-
chological disorders. However, as recommended in a re-
cent review by Grifﬁths and colleagues [48], to account
forpossibleearliertraumasweconsideredinformationper-
taining to comorbid diseases. Furthermore, we collected
dataonother,non-disease-relatedtraumaticeventsthathad
occurred within the previous 3 years. These non-disease-
related events were indeed associated with having more
PTSD symptoms, and altered the initial ORs of the other
factors to the extent that we considered it a moderate con-
founder.
Timing plays an important role in collecting data on
PTSD symptoms in critically ill and ICU patients [48].
We set the period for the recording of PTSD symptoms at
12 months for a very speciﬁc reason; in this severely ill
patient group, we did not want to record patient recovery.
Past studies have shown that critically ill patients develop
PTSD symptoms only after their physical recovery period
has passed, hence with a delayed onset [9].
Although these self-report questionnaires are fre-
quently used, the diagnostic value of such instruments in
relation to a DSM-IV diagnosis obtained by a structured
interview is still being researched and discussed [49].
Some studies have reviewed the diagnostic value of
the questionnaires, but in general these studies were672
methodologically limited [11, 29, 50]. In this study we
did not include a structured clinical interview for estab-
lishing a deﬁnite DSM-IV criteria diagnosis of PTSD,
although this is highly recommended in clinical psychol-
ogy. However, we feel that the use of questionnaires is
more feasible in the ICU [48], and patients who report
many symptoms on these self-report questionnaires [51]
can subsequently be referred to an appropriate mental
healthcare provider [50].
In this study we have tried to learn from two question-
naires, one commonly used and validated in particular for
critically ill patients, together with one of the most fre-
quently used screening instruments for PTSD, the IES-R.
The prevalence of PTSD symptomatology in the present
study was based on whether or not a patient scored above
the cut-offs of the IES-R and the PTSS-10. We employed
the two questionnaires as complementary for the detection
of PTSD symptoms and not to compare results deduced
from both questionnaires separately [49]. Combining the
results of both questionnaires in our analysis was antici-
pated to lead to a more robust assessment of the factors as-
sociated with more PTSD symptoms. Although these two
instruments aim to measure the presence of PTSD symp-
toms, their concordance in classiﬁcation of patients was
not perfect, with 30 patients (28%) being positive on one
questionnaire but not on the other. This demonstrates the
difﬁculty in measuring PTSD symptoms by questionnaire,
but also means that both questionnaires are informative in
their ownright. Combiningthe two instrumentsmay there-
fore lead to a more robust classiﬁcation of patients based
ontheirlevelofPTSD symptomsandmaybeamoreuseful
tool in screening patients following ICU stay, while poten-
tially reducing biases due to instrument variation [52].
WeassessedtraumaticexperiencesduringICU/hospital
stay based on the patients’ recollections (after 1 year).
The patients’ perceived traumatic experience may well
have contributed to the development of PTSD symptoms,
but it is also possible that having PTSD symptoms in-
ﬂuenced their perceptions. Future studies should aim to
prospectively quantify traumatic experiences during or
shortly after ICU stay to draw more causal conclusions,
even though this might be difﬁcult in patients with such
a lengthy recovery period [9, 48, 53, 54].
In the clinical setting, there is a continuing debate
on whether to intervene in the more acute peritraumatic
psychological processes or in a later phase, when symp-
toms or prodromes of PTSD are observed. By improving
our understanding of which factors play an important
role in the development of PTSD, we can better prevent
PTSD symptoms in high-risk patients and decide when
best to intervene. The aim of our predictive model is
for it to be used by treating physicians, following the
acute episode and phase of secondary peritonitis in which
survival and physical recovery are the main concerns, to
recognize high-risk PTSD patients. This relatively simple
model can aid the surgeon, for instance, during the ﬁrst
outpatient visit in determining which patients are at higher
riskforthedevelopmentofPTSD symptoms.However,be-
fore this nomogram can be used to actually predict PTSD
symptomatology in clinical practice, it must be externally
validated in another cohort of patients with secondary
peritonitis.
In conclusion, 10% of peritonitis patients report ‘high’
PTSD symptomatology and another 28% ‘moderate’
PTSD symptoms. Factors that were related to more PTSD
symptoms included younger age, traumatic memories
of the period of hospitalization and length of ICU stay.
Knowledge of these predictive factors is required to in-
crease awareness, and to develop tailored early treatment
options for these high-risk patients our nomogram may
assist in identifying patients with PTSD symptoms.
Open Access. This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
Appendix: RELAP trial clinical centers and
investigators of the Dutch Peritonitis Study Group
All investigators are from departments of surgery unless
speciﬁed as clinical epidemiology and biostatistics (E), in-
tensive care (I) or medical psychology (MP).
O .v a nR u l e r ,K .R .B o e r( E ) ,J .B .R e i t s m a( E ) ,C .W .
Mahler,E. A.Reuland,J.W. O.vanTill, B.C. Opmeer(E),
P. M.M. Bossuyt (E), M.J. Schultz (I), M. A. Sprangers
(MP), H. Obertop, D. J. Gouma, C. A.J.M. de Borgie
(E), M. A. Boermeester: Academic Medical Center,
Amsterdam; E.P. Steller, P. Tanis, H. Hart (I): Sint Lucas
Andreas Hospital, Amsterdam; M. F. Gerhards, M. Guijt,
H.M. Oudemans (I): Onze Lieve Vrouwe Gasthuis,
Amsterdam; K. Bosscha, E. Ritchie, M. Vermeer: Bosch
Medical Centre, Den Bosch; P. W. de Graaf, B. van Etten,
C. Haazer, E. Salm (I): Reinier de Graaf Hospital, Delft;
B. Lamme, E.J. Hesselink, H. Rommes (I): Gelre Hospi-
tals, Lukas Hospital, Apeldoorn; R.J. Oostenbroek, L. te
Velde, G. Govaert, H.H. Ponssen (I): Albert Schweitzer
Hospital, Dordrecht; H.G. Gooszen, M. K. Dinkelman,
L.P. H. Leenen (I): University Medical Centre Utrecht;
E.G.J.M. Pierik, K.W.W. Lansink, J. Bakker (I): Isala
Clinics, Zwolle.
Key staff and steering committee at coordinatingcenter
of RELAP trial: O. van Ruler (investigator),E. A. Reuland
(datamanagement),C. W.Mahler(investigator),J.B.Reit-
sma (epidemiologist), C. A.J.M. de Borgie (epidemiolo-
gist), K.R. Boer (quality of life investigator), B. C. Op-
meer (economist), M. A. Boermeester (principal investiga-
tor, project supervisor) from the Department of Surgery,
Academic Medical Center Amsterdam, The Netherlands.673
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